Publications by Karina Dalsgaard Sørensen

Sorensen KD, Borre M, Orntoft TF, Dyrskjot L, Torring N.
Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer. Int J Cancer. 2007 Oct 17; [Epub ahead of print] PubMed

Sorensen KD, Kunder S, Quintanilla-Martinez L, Sorensen J, Schmidt J, Pedersen FS. Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage. Virology. 2007 May 25;362(1):179-91. Epub 2007 Jan 29. PubMed

Torring N, Borre M, Sorensen KD, Andersen CL, Wiuf C, Orntoft TF. Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array. Br J Cancer. 2007 Feb 12;96(3):499-506. Epub 2007 Jan 23. PubMed

Ma SL, Sorensen AB, Kunder S, Sorensen KD, Quintanilla-Martinez L, Morris DW, Schmidt J, Pedersen FS. The Icsbp locus is a common proviral insertion site in mature B-cell lymphomas/plasmacytomas induced by exogenous murine leukemia virus. Virology. 2006 Sep 1;352(2):306-18. Epub 2006 Jun 15. PubMed

Sorensen KD, Sorensen AB, Quintanilla-Martinez L, Kunder S, Schmidt J, Pedersen FS. Distinct roles of enhancer nuclear factor 1 (NF1) sites in plasmacytoma and osteopetrosis induction by Akv1-99 murine leukemia virus. Virology. 2005 Apr 10;334(2):234-44. PubMed


Sorensen KD, Quintanilla-Martinez L, Kunder S, Schmidt J, Pedersen FS. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns. J Virol. 2004 Dec;78(23):13216-31. PubMed